The IE2 protein of human cytomegalovirus transactivates viral and cellular promoters through a wide variety of cis-elements, but the mechanism of its action has not been well characterized. Here, IE2-Sp1 synergy and IE2-TATA box-binding protein (TBP) interaction are examined by artificial recruitment of either Sp1 or TBP to the promoter. It was found that IE2 could cooperate with DNAbound Sp1. A 117 amino acid glutamine-rich fragment of Sp1, which can interact with Drosophila TAF II 110 and human TAF II 130, was sufficient for the augmentation of IE2-driven transactivation. In binding assays in vitro, IE2 interacted directly with the C-terminal region of Sp1, which contains the zinc finger DNA-binding domain, but not with its transactivation domain, suggesting that synergy between IE2 and the transactivation domain of Sp1 might be mediated by other proteins such as TAF or TBP. It was also found that TBP recruitment to the promoter markedly increased IE2-mediated transactivation. Thus, IE2 acts synergistically with DNA-bound Sp1 and DNA-bound TBP. These results suggest that, in human cytomegalovirus IE2 transactivation, Sp1 functions at an early step such as recruitment of TBP and IE2 acts to accelerate rate-limiting steps after TBP recruitment.
Introduction
Human cytomegalovirus (HCMV), a member of the Betaherpesvirinae, is endemic among the human population. Similar to other herpesviruses, HCMV expresses its genes in three temporal classes : immediate-early (IE), early and late (reviewed by Mocarski, 1996) . The IE genes encode the first set of proteins expressed upon infection, some of which are involved in modulating subsequent events in the virus lifecycle.
One of the most intensely studied IE genes of HCMV is IE2. This 86 kDa phosphonucleoprotein appears to regulate the switch in viral gene expression between the immediateearly and later stages of the HCMV life-cycle. IE2 is a promiscuous transactivator of many cellular and viral promoters, particularly when acting in conjunction with IE1, another IE gene of HCMV (Hermiston et al., 1987 ; Malone et al., 1990 ; Biegalke & Geballe, 1991 ; Hagemeier et al., 1992 a, b ; Arlt et al., 1994 ; Lukac et al., 1994 ; Choi et al., 1995 ;  Author for correspondence : Sunyoung Kim.
Fax j82 2 875 0907. e-mail sunyoung!plaza.snu.ac.kr Schwartz et al., 1996 ; Yoo et al., 1996 ; Kim et al., 1999) . Some aspects of IE2-mediated transcriptional activation are thought to occur via TFIID through direct interaction of IE2 with the TATA box-binding protein (TBP) (Hagemeier et al., 1992 b ; Jupp et al., 1993) . Other studies have revealed that IE2 also binds to additional cellular proteins including TFIIB, Sp1, CBP and Egr-1 (Caswell et al., 1993 ; Lukac et al., 1994 ; Schwarz et al., 1996 ; Yoo et al., 1996 ; Yurochko et al., 1997) . However, the precise mode by which IE2 activates transcription and the mechanism of synergistic cooperation between IE1 and IE2 are not yet fully understood.
Sp1 is a transcription factor that binds to specific GC-rich elements (Dynan & Tjian, 1983 a, b) . It is derived from a single gene product (Kadonaga et al., 1987) and is heavily modified post-translationally. Sp1 is important in the regulation of cellular transcription and is utilized in the regulation of both herpesvirus and non-herpesvirus gene products (Everett et al., 1983 ; Jones et al., 1986 ; Wu et al., 1998) . It has been reported that Sp1 activity is upregulated by HCMV infection and that IE2 can interact physically with Sp1 and can cooperate functionally with Sp1 to increase promoter transactivation (Yurochko et al., 1997 ; Wu et al., 1998) . Furthermore, an enhancement of Sp1 DNA-binding activity by IE2 is suggested as one model of Sp1-IE2 synergy (Yurochko et al., 1997 ; Wu et al., 1998) . However, this perspective does not address the possibility that IE2 may also act synergistically with Sp1 after it binds a promoter.
The binding of TBP or the multisubunit TFIID to the TATA element is the first of a series of steps required for assembly of a transcription-initiation complex on a promoter (Buratowski et al., 1989 ; Koleske & Young, 1994) . For productive transcription to occur, it is believed that activators bound to upstream enhancers can influence the recruitment of TBP and TBP-associated factors (TAFs) to the TATA box, which in turn modulate the docking of the RNA polymerase (RNAP) II holoenzyme at the initiator site (Struhl, 1996) . Consistent with this model, DNA-bound activators have been found to associate with components of the general transcription machinery including TBP, TAFs, TFIIA and TFIIB (Stringer et al., 1990 ; Lin et al., 1991 ; Tjian & Maniatis, 1994 ; Kobayashi et al., 1995) . IE2 differs from typical DNA-binding activators as, although it can bind to DNA through the cis repression signal element and its related sequences (Arlt et al., 1994 ; Pizzorno & Hayward, 1990) , IE2 can also transactivate various promoters in the absence of DNA binding Lukac et al., 1994) . IE2 has been shown to interact directly with TBP (Hagemeier et al., 1992 b) and to stabilize the binding of TBP to the TATA box in vitro (Jupp et al., 1993) . Although this IE2-TBP interaction is consistent with the promiscuous nature of IE2-mediated transactivation of various promoters, it is not yet clear whether stabilization of TBP binding is necessary and\or sufficient for the functional effects of IE2. Furthermore, the fact that IE2 can interact with promoter-bound TBP suggests that IE2 may function at steps subsequent to TBP recruitment.
In this study, we focused on the synergy between Sp1 and IE2 and the relationship between TBP and IE2, in order to understand the mechanism of IE2-mediated transactivation. To investigate the molecular mechanism of the Sp1-IE2 synergy, we addressed several questions. (i) Can artificial recruitment of Sp1 bypass a requirement for IE2 ? (ii) Which domain of Sp1 is required for the augmentation of IE2-mediated transactivation ? (iii) Is protein-protein interaction between IE2 and Sp1 required for Sp1-IE2 synergy ? In addition, we analysed whether artificial recruitment of TBP could bypass the requirement for IE2. Our results demonstrated that IE2 can cooperate with Sp1 that is already bound to DNA and that a 117 amino acid glutamine-rich fragment of Sp1 was sufficient for the augmentation of IE2-driven transactivation. In addition, we showed that IE2 did not interact directly with the transactivation domain of Sp1, but with the C-terminal region that contains the zinc finger DNA-binding domain, suggesting that other proteins such as human (h) TAF II 130 may mediate the Sp1-IE2 interaction. Finally, our data also suggested that IE2 functions at a limiting event(s) after recruitment of TBP to the promoter.
Methods
Plasmids. We used pEQ326 as a mammalian IE2 expression vector (Biegalke & Geballe, 1991) . This plasmid contains the HCMV IE gene region, including the promoter, but lacks exon 4, which specifies IE1. Therefore pEQ326 expresses only IE2. As controls, pEQ336, which contains only the HCMV major IE promoter (MIEP), and pEQ273, which expresses IE1 under the control of HCMV MIEP, were used. Bacterial expression vectors for maltose-binding protein (MBP)-fusion proteins, pMBP-IE2 and pMBP-IE1-4, were described previously (Choi et al., 1995 ; Kim et al., 1996) . pMBP-IE2 contains the full-length IE2 cDNA sequence. pMBP-IE1-4 containing the exon 4 region of IE1 sequence is identical to pMBP-IE1 described by Kim et al. (1996) .
A series of human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) mutant plasmids (p938, p∆κB, p∆Sp1 and p∆TATA) were described previously . Reporter plasmids containing GAL4-binding sites (GAL4BS) were described by Xiao et al. (1997) . Plasmid pGAL-E1b-CAT contains the E1b TATA element (k34 to k22 of the adenovirus E1b promoter region) upstream of the CAT gene and five 17-mer GAL4BS upstream of position k34. Plasmid pGAL-HIV-CAT contains sequences from k43 to j80 of the HIV-1 promoter region with four 17-mer GAL4BS positioned upstream of k43 and CAT positioned downstream of j80. Plasmid pGAL-HIV-CAT\TG is identical to pGAL-HIV-CAT except that the TATAA element has been mutated to TGTAA.
An expression vector pGAL4-VP16, encoding the GAL4 DNAbinding domain (GAL4BD ; amino acids 1-147) fused to the N-terminal activation domain of VP16 (amino acids 413-490), was reported previously (Chun & Jeang, 1996) . Most of the GAL4-Sp1 expression plasmids were reported previously (Gill et al., 1994 ; Emami et al., 1995) ; all plasmids express a fusion protein containing the GAL4BD (amino acids 1-147) and a portion of Sp1. pGAL4-Sp1 contains Sp1 amino acids 83-778 and is the same as GAL4-Sp1WT of Gill et al. (1994) . pGAL4-Sp1(A), pGAL4-Sp1(B) and pGAL4-Sp1(B) contain Sp1 amino acids 83-262, 263-542 and 425-542, respectively. pGAL4-Sp1(B) contains Sp1 amino acids 263-448 and was constructed by inserting a fragment from pGAL4-Sp1(B) into expression vector pBXG1 (Emami et al., 1995) . The GAL4-Sp1(B) fragment was amplified by PCR with the following primers complementary to the 5h end of the GAL4 fragment and to the 3h end of Sp1(B) domain, respectively : 5h AAGCTTCCTGAAAGA-TGAAGCTA 3h and 5h GATTTCTAGATTACACTGTTGGTGTCC-GGAT 3h. The amplified products were cleaved with HindIII and XbaI and inserted into the same sites in plasmid pBXG1, resulting in pGAL4-Sp1(B). The expression vectors encoding the GAL4BD (amino acids 1-147) fused to hTBP (amino acids 2-339), hTBP∆N (amino acids 94-339) or hTBP M$ were reported previously (Xiao et al., 1997) .
For in vitro transcription and translation, a series of Sp1 deletion mutant expression vectors were constructed. For construction of pCR2.1-Sp1(83-778), pCR2.1-Sp1(83-621) and pCR2.1-Sp1(543-778), Sp1 cDNAs encoding amino acids 83-778, 83-621 and 543-778 were generated by PCR using pGAL4-Sp1 as template and the appropriate oligonucleotide primers. The sequences of the primers used were as follows : 5h primer for Sp1(83-778) and Sp1(83-621), 5h GAATTCA-TGACAGGTGAGCTTGACCTC ; 5h primer for Sp1(543-778), 5h GAATTCATGCTGCCGTTGGCTATAGCA ; 3h primer for Sp1(83-778) and Sp1(543-778), 5h TCTAGATCAGAAGCCATTGCCACTG-AT ; and 3h primer for Sp1(83-621), 5h TCTAGATCAGCAAATAT-GCTGTTTCTT. The amplified DNA fragments were cloned into the pCR2.1 vector (Invitrogen).
DNA transfection. Promoter activities were assessed by transiently transfecting BHK21 and human foreskin fibroblast (HFF) cells with DI IE2 function at steps after TBP recruitment IE2 function at steps after TBP recruitment promoter-CAT constructs and assaying for CAT activity. Procedures for DEAE-dextran transient transfection, CAT assay and quantification have been described previously (Choi et al., 1995) . The total amount of DNA per transfection was always adjusted to the same amount within each experiment by using appropriate control plasmids.
IE2-Sp1 binding assay. To generate in vitro-translated proteins, expression vector DNA (1 µg) was incubated with a TNT-coupled reticulolysate system (Promega) in the presence of [$&S]methionine as described previously (Choi et al., 1995) . MBP-fusion protein expression and purification were carried out as described previously (Choi et al., 1995) .
For protein-binding assays, 500 ng MBP-fusion protein, on beads, was rocked for 3 h at 4 mC with 5 µl in vitro-translated test protein in a final volume of 250 µl in buffer A (100 mM Tris-HCl, pH 7n4, 140 mM NaCl, 0n5 % Nonidet P-40,1 mM DTT, 0n1 mM PMSF). The beads were then washed five times in 1 ml buffer A, pelleted at 500 g for 30 s and boiled in 4i SDS-PAGE sample buffer. Gels were fixed and incubated with a fluorograph for 30 min prior to drying and autoradiography.
Results

Role of the Sp1 sites in IE2-mediated transactivation
Because the HIV-1 LTR has been shown to be highly activated by IE2 and cis-acting sequences of this promoter have already been well characterized (Biegalke & Geballe, 1991 ; Hagemeier et al., 1992 b ; Choi et al., 1995) , we first used the HIV-1 LTR to analyse the transactivational activity of IE2. To identify the nucleotide sequences responsible for IE2-mediated transactivation, we used a series of mutants that specifically lacked one of the three major transcriptional elements of the HIV-1 LTR promoter, NF-κB, Sp1 and the TATA box. p∆κB has point mutations in the κB sites, as reported by Nabel & Baltimore (1987) , whereas the Sp1 sites and TATA box were selectively removed and replaced by restriction linkers in plasmids p∆Sp1 and p∆TATA, as reported previously . These mutant constructs were transfected into BHK21 cells and transient expression of the CAT gene was BHK21 cells were transfected with 1 µg mutant HIV-1 LTR-CAT fusion constructs in the presence or absence of 2 µg IE2-expressing plasmid pEQ326 (Biegalke & Geballe, 1991) by the DEAE-dextran method. As a control for plasmid pEQ326, pEQ336 containing no IE coding sequence was used to maintain an equal total amount of DNA in the transfections. Cells were harvested and assayed for CAT activity 48 h after transfection. Transfection and CAT assays were performed more than four times for each construct. Relative CAT activity was calculated by dividing each activity by the activity of cells transfected with p938 without IE2.
used to measure the contribution of these elements to IE2-driven transactivation of the HIV LTR. As shown in Fig. 1 , mutation of the κB sites had little effect on both basal and IE2-mediated gene expression from the LTR. Mutations in the TATA box slightly lowered CAT activity, but overall the magnitude of activation did not change. In contrast, removal of the three Sp1 sites lowered significantly the ability of the LTR to respond to IE2. These results suggested that Sp1-binding sites could play an important role in IE2-mediated transactivation of the HIV-1 LTR.
IE2 cooperates with DNA-bound Sp1
It has been reported that IE2 can increase the DNA-binding activity of Sp1 (Yurochko et al., 1997 ; Wu et al., 1998) . To test whether the IE2-Sp1 synergy is due solely to an increase in Sp1 DNA-binding activity by IE2, we devised an experiment to test whether activation of a minimal adenovirus E1b promoter by artificial recruitment of Sp1 would bypass a requirement for IE2. We used a fusion construct containing the DNA-binding domain of GAL4 (GAL4BD ; amino acids 1-147) fused to Sp1 (amino acids 83-778). As a control, a GAL4BD-VP16 fusion protein was used, which contains the activation domain of VP16 (amino acids 413-490) in place of Sp1. For functional readouts, we used a minimal promoter-CAT reporter (pGAL-E1b-CAT) containing five synthetic GAL4BS and the adenovirus E1b TATA element from k34 to k22. It has been shown previously that the pGAL-E1b-CAT reporter permits artificial docking of GAL4BD-activator fusion proteins to the five upstream GAL4BS, thereby recruiting these factors to an E1b promoter-proximal location (Xiao et al., 1997) . In this context, if IE2 functions simply by recruiting Sp1 to the promoter, the artificial tethering of Sp1 via the GAL4BD-GAL4BS interaction should bypass the requirement for IE2. On the other hand, if IE2 functions other than by Sp1 DJ J.-M. Kim and others J.-M. Kim and others Fig. 2 . Activation of the E1b promoter by GAL4-Sp1 or GAL4-VP16 in the presence or absence of HCMV IE2. As a reporter plasmid, the pGALE1b-CAT fusion construct was used in transfections. It contains sequences from k34 to k22 of the adenovirus E1b promoter region containing the E1b TATA element, with five 17-mer GAL4BS positioned upstream of k34 and CAT positioned downstream of k22. pGAL4-Sp1 and pGAL4-VP16 were used as activator plasmids. BHK21 cells were transfected by DEAE-dextran with 1 µg pGAL-E1b-CAT and 2 µg of the GAL4-fusion constructs together with 2 µg of either the control plasmid pEQ336, the IE1-expressing plasmid pEQ273 or the IE2-expressing plasmid pEQ326. Transfections and CAT assays were done as described in Fig. 1 and performed at least three times for each construct. Relative CAT activity was calculated by dividing each activity by the activity of cells cotransfected with pGAL-E1b-CAT and pGAL4(1-147) in the absence of the IE proteins. The latter plasmid contains only the GAL4BD.
recruitment, an activator-IE2 combination should be additive or synergistic.
First, we examined the ability of IE2 to cooperate with Sp1. BHK21 cells were transfected with pGAL-E1b-CAT and pGAL4-Sp1 in the presence or absence of an IE2-expressing plasmid. At 48 h post-transfection, CAT activities were quantified in the linear range of the enzyme assay. As shown in Fig. 2 , GAL4-Sp1 activated pGAL-E1b-CAT expression in the absence of IE2. However, the addition of IE2 resulted in a further activation that was 8-fold greater than that seen with GAL4-Sp1 alone. As a control, a similar experiment was performed with GAL4-VP16. VP16 greatly increased the CAT activity from pGAL-E1b-CAT, but IE2 had no effect on such activation. The synergy between IE2 and Sp1 was specific for IE2, since IE1 had little effect on Sp1-mediated transactivation under the same conditions. We obtained similar results by using HFF cells, which are known to be permissive for HCMV infection (data not shown). These results suggested that IE2 could cooperate with DNA-bound Sp1 and that the synergy between Sp1 and IE2 might not only be due to enhancement of Sp1 DNA-binding by IE2.
A 117 amino acid glutamine-rich fragment of Sp1 is sufficient for the augmentation of IE2-driven transactivation
To localize the domains of Sp1 involved in the IE2-mediated transactivation, various N-terminal Sp1 subfragments were tested as GAL4-fusion proteins. Previous studies of Sp1 in cultured Drosophila cells revealed that the N terminus contains two distinct domains, A and B, each containing a glutamine-rich stretch and an adjacent region rich in serines and threonines (Courey & Tjian, 1988) . In mammalian cells, each of the glutamine-rich domains alone was found to be sufficient for transcriptional activation (Gill et al., 1994) . Moreover, the C-terminal half of the B domain (B) was found to activate transcription to a similar extent as the entire B domain, but the N-terminal half (B) was inactive (Gill et al., 1994) .
BHK21 cells were transfected with pGAL-E1b-CAT together with plasmids that expressed the GAL4 DNAbinding domain fused to the A, B, B or B subdomains of Sp1 in the presence or absence of IE2-expressing plasmids. The analysis of CAT activity showed that the A, B and B fragments of Sp1 could all augment IE2-mediated transactivation to a similar extent as the full-length Sp1 (Fig. 3) , but GAL4-Sp1(B) enhanced IE2-mediated transactivation only weakly. It has been shown previously that B alone does not interact with Drosophila (d) TAF II 110 (Gill et al., 1994) . This suggests that a direct interaction between Sp1 and hTAF II 130, the human homologue of dTAF II 110, may underlie the augmentation of IE2-mediated transactivation.
IE2 interacts directly with the C-terminal region of Sp1
It has been reported that IE2 can interact with Sp1 in vitro (Lukac et al., 1994 ; Yurochko et al., 1997) . To localize the domain of Sp1 that interacts with the IE2 protein, an in vitro binding assay was performed by using an MBP-IE2 fusion protein and three in vitro-translated, [$&S]methionine-labelled Sp1 proteins ; the full-length Sp1 protein (83-778), Sp1(83-621), containing only the N-terminal domain, and Sp1(543-778), containing the C-terminal zinc finger domain. As expected from the findings of Yurochko et al. (1997) , the fulllength, [$&S]methionine-labelled Sp1 protein was retained by the MBP-IE2 resin (Fig. 4, lane 3) and MBP-IE1-4 (lane 4), but not by the resin containing MBP alone (lane 2). Similarly, in vitro-translated and radiolabelled Sp1(543-778) bound the MBP-IE2 resin (Fig. 4, lane 11) and the MBP-IE1-4 resin (lane 12), but not the control resin (lane 10). Sp1(83-621) was retained by MBP-IE1-4 resin (lane 8) but not by the resin containing MBP or MBP-IE2 (lanes 6 and 7). Taken together, these results demonstrate that IE2 interacts directly with the C-EA IE2 function at steps after TBP recruitment IE2 function at steps after TBP recruitment Fig. 3 . Effects of the various Sp1 deletion mutants on transcriptional activation of the E1b promoter. One µg pGAL-E1b-CAT and 2 µg of each GAL4BD-fused Sp1 deletion mutant were co-transfected with or without the IE2-expressing plasmid pEQ326. pEQ336 was used as a control plasmid to keep the total amount of DNA in each transfection the same. Transfections and CAT assays were done as described in Fig. 1 and performed more than four times for each construct. Relative CAT activity was calculated by dividing each activity by the activity of cells co-transfected with pGAL-E1b-CAT and pGAL4(1-147) in the absence of IE2. terminal region of Sp1, which contains the zinc finger DNAbinding domain, but not with the activation domain. Therefore, the synergy between IE2 and the activation domain of Sp1 does not appear to require direct protein-protein interaction.
IE2 functions after TBP recruitment
The previous findings suggested that the B transactivation domain of Sp1 was sufficient to confer augmentation of IE2-mediated transactivation. This region of Sp1 has been demonstrated to interact with hTAF II 130 (Saluja et al., 1998) , which in turns binds to TAF II 250, thereby bridging Sp1 with TBP (Chen et al., 1994) .
TBP recruitment to the promoter is an early defining step of initiation-complex formation (Stargell & Struhl, 1996 ; Struhl, 1996 ; Ptashne & Gann, 1997) . To characterize more precisely the function(s) of IE2 in transcription, we asked whether artificial recruitment of TBP could bypass the requirement for EB J.-M. Kim and others J.-M. Kim and others Fig. 5 . Activation of the E1b promoter by GAL4-hTBP or GAL4-hTBP∆N in the presence or absence of IE2. pGAL-E1b-CAT was used in the transfections as a reporter plasmid and plasmids pGAL4-hTBP and pGAL4-hTBP∆N were used as activator plasmids. pGAL4-hTBP contains the entire hTBP fused to the GAL4BD ; pGAL4-hTBP∆N is identical to pGAL4-hTBP except that the N-terminal amino acids 1-93 were deleted. BHK21 cells were co-transfected by DEAE-dextran with 1 µg pGAL-E1b-CAT together with 2 µg of either the control plasmid pEQ336, the IE1-expressing plasmid pEQ273 or the IE2-expressing plasmid pEQ326. Transfections and CAT assays were done as described for Fig. 1 and performed at least three times for each construct. Relative CAT activity was calculated by dividing each activity by the activity of cells co-transfected with pGAL-E1b-CAT and pGAL4(1-147) in the absence of the IE proteins.
IE2. We approached this question by using a GAL4BD-hTBP hybrid protein that, when assayed for its ability to enhance transcription from the pGAL-E1b-CAT plasmid, addresses whether recruitment of TBP is a rate-limiting step accelerated by IE2. Because GAL4 binds DNA even when packaged into nucleosomes, in principle, GAL4-hTBP would be recruited efficiently to the GAL4BS in plasmid pGAL-E1b-CAT. Accordingly, if the function of IE2 is only to recruit TBP to the promoter, then artificial tethering of TBP via the GAL4BD-GAL4BS interaction should bypass the requirement for IE2. Indeed, this type of tethering approach has been used to document TBP recruitment as a major rate-limiting step in transcription from many yeast promoters (Chatterjee & Struhl, 1995 ; Xiao et al., 1995) .
BHK21 cells were transfected with plasmids pGAL-E1b-CAT and pGAL4-hTBP in the presence or absence of an IE2-expressing plasmid. At 48 h after transfection, CAT activities were quantified in the linear range of the enzyme assay. As shown in Fig. 5 , GAL4-hTBP activated pGAL-E1b-CAT expression in the absence of IE2. Addition of IE2 resulted in a 5-fold greater activation than was seen with either GAL4-hTBP or IE2 alone. Synergy with TBP was specific for IE2, since IE1 had little effect on TBP-mediated transactivation under the same conditions. We obtained similar results with another reporter construct, pGAL-HIV-CAT, which contains four synthetic GAL4BS and the HIV-1 TATA-TAR sequences from k43 to j80 (data not shown). We also obtained similar results by using HFF cells, which are known to be permissive for HCMV infection (data not shown). The slight increase in minimal E1b promoter activity in the presence of IE2 alone is due presumably to the constitutive docking of some native hTBP at the pGAL-E1b-CAT TATA element. Overall, these results are consistent with a simple interpretation that IE2 can act at one or more steps after TBP recruitment.
TBP has been described as possessing a ' fortuitous ' activation domain (Seipel et al., 1993) . Hence, an alternative interpretation of the above results could be that GAL4-hTBP did not provide natural TBP function at the promoter (i.e. interaction of GAL4-hTBP with TATA followed by recruitment of RNAP II holoenzyme) but instead functioned simply as a conventional upstream activator, working in a manner similar to Sp1, in recruiting endogenous hTBP to TATA. To exclude such a possibility, control experiments were performed. First, we used the pGAL4-hTBP∆N expression plasmid, which is the same as pGAL4-hTBP except that the N-terminal amino acids 1-93 were deleted. It was reported previously that the TBP N-terminal region acts as an auxiliary activation domain that reinforces the activity of other promoter-bound factors (Seipel et al., 1993) . We asked whether GAL4-hTBP∆N would yield equivalent findings when assayed in place of GAL4-hTBP. We observed that deletion of the activation domain of hTBP had no effect on the IE2-hTBP synergy (Fig. 5) . Thus, the N-terminal activation domain of TBP does not contribute to IE2-mediated transactivation.
Second, we compared GAL-hTBP with a mutant derivative, GAL4-hTBP M$ , for their ability to activate transcription from a TGTA element in the HIV-1 promoter. Previous studies have shown that an A-to-G substitution at the second position of TATA greatly reduces its affinity for TBP and that promoters with TGTA elements are transcriptionally inactive in both yeast and human cells (Strubin & Struhl, 1992 ; Tansey et al., 1994) . It has been demonstrated that a TGTA promoter can be trans-complemented with an altered-specificity TBP mutant, TBP M$ (Strubin & Struhl, 1992) . We therefore used this property to analyse TBP-IE2 synergy, by using pGAL-HIV-CAT\TG, which was identical to pGAL-HIV-CAT except that the HIV-1 TATAA was changed to TGTAA. We reasoned that if TBP in GAL4-hTBP functions by direct binding to the TATA element, one would expect the A-to-G change to affect transcription dramatically from a TGTA promoter mediated through wild-type GAL4-hTBP but not through GAL4-hTBP M$ . Indeed, the A-to-G substitution dramatically reduced synergistic activation by wild-type GAL4-hTBP and IE2, but had a minimal affect on synergy between mutant GAL4-EC IE2 function at steps after TBP recruitment IE2 function at steps after TBP recruitment Fig. 6 . Effects of TATA mutations on transcriptional activation of the HIV-1 promoter by GAL4-hTBP or GAL4-hTBP M3 fusion proteins in the presence or absence of IE2. pGAL-HIV-CAT and pGAL-HIV-CAT/TG were used as reporter plasmids. pGAL-HIV-CAT/TG is identical to pGAL-HIV-CAT except that the TATAA element has been changed to TGTAA by site-directed mutagenesis. pGAL4-hTBP and pGAL4-hTBP M3 were used as activator plasmids. pGAL4-hTBP M3 is the same as pGAL4-hTBP except that it contains three point mutations in the conserved core domain, which confer a new DNA-recognition specificity to TBP for the TGTAA sequence. However, this mutant TBP still retains the ability to recognize the wild-type TATAA sequence. The interactions of wild-type GAL4-hTBP and mutant GAL4-hTBP M3 fusion proteins with wild-type TATA or mutant TGTA elements are presented schematically in (A) and (B), respectively. Relative CAT activities are shown after transfection of 1 µg reporter plasmid and 2 µg of either pGAL4-hTBP or pGAL4-hTBP M3 , with or without 2 µg of an IE2-expressing plasmid, pEQ326, into BHK21 cells by DEAE-dextran. Transfection and CAT assays were performed as for Fig. 1 and done more than four times. Relative CAT activity was calculated by dividing each activity by the activity of cells co-transfected with pGAL-HIV-CAT and either pGAL4-hTBP (A) or pGAL4-hTBP M3 (B) in the absence of IE2.
hTBP M$ and IE2 (Fig. 6 ). Since endogenous hTBP cannot dock at TGTA, if GAL4-hTBP M$ supplied an activation domain function for purposes of recruiting endogenous hTBP, one would not expect to see an increase in IE2-dependent activity from the TGTA promoter. The fact that activation was observed is fully consistent with a model of IE2 action at a step after recruitment of mutant GAL4-hTBP M$ at TGTA or wildtype GAL4-hTBP at TATA.
Supplying the activation domain of Sp1 can bypass the requirement for the TATA box in IE2-mediated transactivation
The data shown in Fig. 6 suggested that the TATA box was essential for IE2-mediated transactivation of the HIV-1 LTR containing only the minimal portion of promoter elements. This result is consistent with the previous report that IE2 transactivates heterologous promoters in a TATA boxdependent manner (Hagemeier et al., 1992 b) . On the other hand, the result shown in Fig. 1 indicated that mutations in the TATA box did not abolish IE2-mediated transactivation of HIV-1 LTR. The difference between these two experiments producing seemingly contradictory results is that p∆TATA used in the experiment shown in Fig. 1 contains binding sites for various upstream transcription factors including Sp1, while pGAL-HIV-CAT\TG used in the experiment shown in Fig. 6 contains the minimal region of LTR starting from k43. Because Sp1 appears to play an important role in IE2-mediated transactivation, we tested whether artificial recruitment of Sp1 could affect the dependence of IE2-mediated transactivation on the TATA box.
pGAL-HIV-CAT\TG was co-transfected into BHK21 cells together with pGAL4-Sp1, pGAL4-Sp1B or pGAL4-Sp1B in the presence or absence of an IE2-expressing plasmid. The analysis of CAT activity showed that, in the presence of fulllength Sp1 or the truncated Sp1 containing only the B transactivation domain, IE2 could greatly activate gene expression from the promoter containing the mutated TATA ED J.-M. Kim and others J.-M. Kim and others Fig. 7 . Effects of the various Sp1 deletion mutants on transcriptional activation of the HIV-1 LTR containing the mutated TATA sequence. One µg pGAL-HIV-CAT/TG and 2 µg of plasmids expressing each GAL4BD-fused Sp1 deletion mutant were co-transfected with or without the IE2-expressing plasmid pEQ326. pEQ336, containing no IE2 coding sequence, was used as a control plasmid to keep the total amount of DNA in each transfection the same. Transfections and CAT assays were done as described in Fig. 1 and performed more than four times for each GAL4-fusion construct. Relative CAT activity was calculated by dividing each activity by the activity of cells co-transfected with pGAL-HIV-CAT/TG and pGAL4(1-147) in the absence of IE2.
box (Fig. 7) . IE2 had little effect on that promoter in the presence of Sp1 containing only the B subdomain. These results suggested that the presence of the activation domain of Sp1 alone could allow IE2 to bypass the requirement for the TATA box in its transactivation of the promoter.
Discussion
In this study, we have demonstrated that IE2 can cooperate with DNA-bound Sp1 and DNA-bound TBP to enhance transcription. Taken together, these observations suggest that Sp1 may provide the required first step that allows for subsequent IE2 activation by recruiting TBP (Emili et al., 1994 ; Blau et al., 1996) .
Artificial recruitment of Sp1 to the promoter through its attachment to a heterologous DNA-binding domain can trigger gene transcription. Addition of IE2 can augment such Sp1-mediated transactivation, suggesting that IE2 can cooperate with DNA-bound Sp1. Analysis of a series of Sp1 deletion mutants revealed that the B subdomain of Sp1 is sufficient for the augmentation of IE2-mediated transactivation, while the B subdomain had little effect. It has been reported previously that the B domain can interact with hTAF II 130, while the B subdomain of Sp1 failed to interact with hTAF II 130 (Saluja et al., 1998) . Therefore, it is possible that the interaction between Sp1 and hTAF II 130 may be important for IE2-Sp1 synergy.
The interaction between IE2 and Sp1 appears to be mediated by the C terminus of Sp1, which contains the zinc finger DNA-binding domain. It has been suggested previously that zinc fingers, in addition to binding DNA and RNA, may mediate protein-protein interactions. For instance, the zinc fingers of YY1 have been shown to be involved in physical interactions with Sp1, p300 and bZIP-containing proteins such as CREB (Lee et al., 1993 (Lee et al., , 1995 Zhou et al., 1995) . IE2 has also been shown to interact with the zinc fingers of Egr-1 (Yoo et al., 1996) . The observation that IE2 can interact directly with the DNA-binding domain of Sp1 may underlie the enhancement of Sp1 DNA-binding activity by IE2 (Wu et al., 1998) . It has been reported that HIV-1 Tat interacts directly with Sp1 and that Tat cooperates with DNA-bound Sp1 (Jeang et al., 1993 ; Xiao et al., 1997) . The interaction between these two proteins appears to modulate Sp1 phosphorylation in a double-stranded DNA-dependent protein kinase-dependent manner (Chun et al., 1998) . Because IE2 has features similar to Tat in regard to its relationship with Sp1, it will be interesting to test whether IE2 can regulate the function of Sp1 by modulating the phosphorylation of this protein.
IE2 has been shown to interact with TBP (Hagemeier et al., 1992 b) and to stabilize the binding of TBP to the TATA box (Jupp et al., 1993) . However, it is not yet clear whether IE2 can function at steps after TBP recruitment. To test whether IE2 can act at steps subsequent to TBP recruitment, we posed a simple question : would artificial recruitment of hTBP to the promoter bypass a transcriptional requirement for IE2 ? We found that GAL4BD-based recruitment of TBP alone could increase expression from a minimal promoter, but that the addition of IE2 to this ensemble increased transcription markedly from the promoter. These findings suggest that the IE2 enhancement of promoter function occurs at steps after TBP recruitment. Deletion of the N-terminal activation domain of TBP had little effect on IE2-TBP cooperation, suggesting that IE2-activated transcription probably occurs through an IE2-dependent step after TBP recruitment rather than as a consequence of interactions between the activation domain of TBP and IE2. When considered in the context of a two-step model of transcriptional activation (Stargell & Struhl, 1996) , the upstream DNA-bound factors such as Sp1 serve primarily to recruit TBP, whereas the IE2 protein appears to act at later steps.
It has been reported that the TATA box is essential for IE2-mediated transactivation (Hagemeier et al., 1992 b) . Our finding that an A-to-G substitution in the HIV-1 TATA box dramatically reduced synergistic activation by hTBP and IE2 is consistent with the previous report (Hagemeier et al., 1992 b) . However, in the presence of the activation domain of Sp1, IE2 can greatly activate gene expression from the promoter containing the mutated TATA sequence. The EE IE2 function at steps after TBP recruitment IE2 function at steps after TBP recruitment glutamine-rich activation domain of Sp1 has been shown to stimulate Inr-containing core promoters preferentially (Emami et al., 1995) . During IE2 activation, the activation domain of Sp1 appears to be able to recruit TBP independently of the TATA box. Indeed, it was reported that Sp1, possibly through an Sp1-TAF interaction, recruits TFIID to an Inr element directly in the absence of a TATA box (Kaufmann & Smale, 1994) .
Events occurring at the promoter after TBP engagement are numerous and complex (Buratowski et al., 1989 ; Zawel & Reinberg, 1993) . In this area, one could propose that IE2 functions directly or indirectly to recruit either additional general transcription factors or the RNAP II holoenzyme. Indeed, consistent with such a hypothesis is the fact that IE2 has been shown to interact with transcription factors such as TFIIB and hTAF II 130 (Caswell et al., 1993 ; Lukac et al., 1997) . The observations that IE2 is capable of binding both TFIIB and TBP and that the binding regions overlap but are not identical imply that IE2 may be capable of interacting with both factors simultaneously (Caswell et al., 1993) . This suggests a model by which IE2 might act through general transcription factors, that is by increasing the rate of assembly of the pre-initiation complex.
